Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,326 recruiting studies in this area right now.
By phase
- Not applicable4,387
- Phase 2611
- Phase 1413
- Phase 3322
- Phase 4268
- Phase 1/Phase 2255
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer340
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer191
- Acute Kidney Injury136
- Endometriosis135
- Chronic Kidney Diseases131
- Pregnancy131
- Breast Cancer106
- Chronic Kidney Disease105
- Infertility95
- Renal Cell Carcinoma80
- Colorectal Cancer76
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Urinary Incontinence64
- Lung Cancer62
Leading sponsors
- Mayo Clinic58
- Assistance Publique - Hôpitaux de Paris47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- AstraZeneca36
- University of Aarhus36
Where studies are running
- California345
- Alabama156
- Texas121
- Massachusetts119
- New York118
- Arizona102
- Florida101
- Colorado90
- Maryland90
- Illinois79
Recruiting studies6,326 total
- NCT04715191RecruitingPhase 1
CAR T therapy for GPC3-positive pediatric solid tumors
This Phase 1 study tests a customized immune-cell treatment (CAR T cells) made to recognize GPC3, a marker found on some tumors. It’s designed for children and young people whose solid tumors have not been cured by standard treatment and who can safely receive this therapy.
Houston, TexasAges 1–21 - NCT06386887Recruiting
Fasting During Chemotherapy for Ovarian Cancer
This trial tests whether adding periods of fasting to standard chemotherapy before surgery helps people with advanced ovarian cancer. It is for those receiving platinum-based chemo for the first time or after recurrence.
Cleveland, OhioAges 18 years+ - NCT07241390RecruitingPhase 3
Study of orforglipron for heart and kidney health.
This trial tests if orforglipron can reduce the risk of heart attack, stroke, or kidney failure in people with heart disease or chronic kidney disease.
Bahía BlancaAges 50 years+ - NCT07750249Enrolling by invitationEarly Phase 1
Short-chain fatty acids for IgA nephropathy
This trial tests whether a daily supplement of short-chain fatty acids (SCFAs) can slow down kidney damage in people with IgA nephropathy. SCFAs are substances made by gut bacteria that may help reduce inflammation and protect the kidneys.
MartinAges 18 years+ - NCT07202884RecruitingPhase 3
Orforglipron for Women with Stress Incontinence and Overweight
This study tests an oral medication called orforglipron to see if it helps women with stress urinary incontinence who are also overweight or have obesity. The medicine may reduce leaking episodes and also help with weight loss.
Birmingham, AlabamaAges 18 years+ - NCT07114601RecruitingPhase 1
Study of LY4257496 for people with GRPR-positive solid tumors
This trial tests a new drug, LY4257496, in people with certain types of cancer that have a protein called GRPR on their cells. The study aims to see if the drug can help shrink tumors or slow the cancer's growth.
Duarte, CaliforniaAges 18 years+ - NCT07227168RecruitingPhase 1
Study of STRO-004 for advanced solid tumors
This trial tests a new drug called STRO-004 for people with advanced solid tumors (cancers that have spread or come back). It aims to see if the drug is safe and effective for those who have already tried other treatments.
San Diego, CaliforniaAges 18 years+ - NCT07279571Recruiting
AI chatbot education for gynecologic cancer patients
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
Los Angeles, CaliforniaAges 18 years+ - NCT07048769RecruitingPhase 4
Pain relief shot for saline ultrasound of the uterus
This trial tests if a numbing injection in the cervix reduces pain during a saline ultrasound that checks the uterus and fallopian tubes. It might help make the procedure more comfortable for you.
Hartsdale, New YorkAges 18–50 - NCT07067554Recruiting
Breastfeeding myths and mother motivation study
This study looks at how common myths about breastfeeding affect mothers' motivation. It is for mothers with a baby aged 0-6 months who have breastfed at least once.
Istanbul, AtaşehirAges 18 years+ - NCT07043647Recruiting
Farming support for pregnant women with food insecurity
This study tests a farming support program for pregnant women who are having trouble getting enough food. The goal is to see if growing their own food can improve nutrition and health for both mom and baby.
NairobiAges 16 years+ - NCT07075731Recruiting
Cervical and endometrial cancer screening before gender-affirming hysterectomy
This study looks at how to best screen for cervical and endometrial (uterine lining) cancer in transgender and gender-diverse people who have had or plan to have a hysterectomy (surgery to remove the uterus and cervix). It aims to make screening more comfortable and effective for this community.
Minneota, MinnesotaAges 18 years+ - NCT07062367Recruiting
Anesthesia options for laparoscopic hysterectomy and brain health
This study compares three ways to give anesthesia during laparoscopic hysterectomy: one type of gas (sevoflurane) with or without a lidocaine IV drip, versus a different IV anesthesia (propofol). The goal is to see which approach best protects pressure inside your head and oxygen levels in your brain during surgery.
Tanta, El-GharbiaAges 18–65 - NCT07088146RecruitingPhase 4
Dexamethasone to prolong spinal anesthesia in C-section
This study tests whether giving dexamethasone (a steroid) during spinal anesthesia can make the numbness last longer during a planned C-section. It may help reduce the need for extra pain medicine after surgery.
Rawalpindi, Punjab ProvinceAges 16–40 - NCT07006324Recruiting
Home visits for high-risk postpartum parents in Mississippi Delta
This program offers home visits after childbirth for mothers and parents in the Mississippi Delta who had a high-risk pregnancy. It aims to provide support and care to help you and your baby stay healthy.
Jackson, MississippiAges 18–45 - NCT07008950Recruiting
Health education for Syrian refugee young women in Lebanon
This study tests a program to help Syrian refugee women and girls learn about their bodies, relationships, and how to stay healthy. It aims to give them confidence and knowledge to make informed choices.
BeirutAges 15–15 - NCT07087171Recruiting
AI tool for patient engagement in fertility treatment
This trial tests a new AI tool designed to help patients actively participate in their own fertility care. It may benefit people starting or considering medically assisted reproduction treatments like IVF or artificial insemination.
LisbonAges 18–45 - NCT07018362Enrolling by invitation
Ultrasound study of fetal growth in healthy pregnancies
This study uses ultrasound to check how well your baby is growing during pregnancy. It helps doctors understand normal growth patterns so they can better care for you and your baby.
Xiamen, FujianAges 18–45 - NCT06975683Recruiting
PRGF ovarian injection for low ovarian reserve
This study tests a special injection of growth factors from your own blood into the ovary to see if it can improve egg quality and quantity for women with low ovarian reserve. It may be an option if you have been trying to conceive for over a year and have low egg reserve.
MadridAges 18–50 - NCT06965790Recruiting
Individualized contrast dose CT study for men and women
This trial tests a personalized way to calculate contrast dye for CT scans, based on your sex and body measurements. It may improve safety and image quality.
Augsburg, BavariaAges 18 years+ - NCT06975111RecruitingPhase 2/Phase 3
Improving health during menopause
This trial studies ways to help women during the late menopausal transition. It uses a smartphone app and telehealth visits to track your health and help you feel better.
Aurora, ColoradoAges 45–55 - NCT06942598Recruiting
Food support program for pregnant women facing food insecurity
This trial tests a program to help pregnant women who have trouble getting enough food. It provides special meals and support to improve food security and health for both mother and baby.
Winston-Salem, North CarolinaAges 18 years+ - NCT06813261Recruiting
GLYLO supplement trial for aging in postmenopausal women
This trial tests whether a supplement called GLYLO can reduce markers of aging related to sugar damage in postmenopausal women. It may help if you are between 45 and 65, have some extra belly fat or higher blood sugar, and are not taking certain medications.
Novato, CaliforniaAges 45–65 - NCT06828406Recruiting
Shared decision-making huddles for labor
This study tests if a short team huddle during labor helps parents feel safer, heard, and more involved in their care. It aims to improve the birth experience and make care more equal for everyone.
Arlington Heights, IllinoisAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,326 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,202 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.